GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Shiller PE Ratio

Novartis AG (MEX:NVS N) Shiller PE Ratio : 19.81 (As of May. 07, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Shiller PE Ratio?

As of today (2025-05-07), Novartis AG's current share price is MXN2235.00. Novartis AG's E10 for the quarter that ended in Mar. 2025 was MXN112.85. Novartis AG's Shiller PE Ratio for today is 19.81.

The historical rank and industry rank for Novartis AG's Shiller PE Ratio or its related term are showing as below:

MEX:NVS N' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.78   Med: 17.21   Max: 21.68
Current: 18.8

During the past years, Novartis AG's highest Shiller PE Ratio was 21.68. The lowest was 12.78. And the median was 17.21.

MEX:NVS N's Shiller PE Ratio is ranked better than
63.74% of 524 companies
in the Drug Manufacturers industry
Industry Median: 24.18 vs MEX:NVS N: 18.80

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2025 was MXN37.234. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is MXN112.85 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novartis AG Shiller PE Ratio Historical Data

The historical data trend for Novartis AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Shiller PE Ratio Chart

Novartis AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.66 16.02 16.45 16.42 16.69

Novartis AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.75 18.18 18.44 16.69 19.79

Competitive Comparison of Novartis AG's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.


;
;

Novartis AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2235.00/112.85
=19.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=37.234/107.7224*107.7224
=37.234

Current CPI (Mar. 2025) = 107.7224.

Novartis AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 11.768 100.464 12.618
201509 13.011 99.785 14.046
201512 7.566 99.386 8.201
201603 14.460 99.475 15.659
201606 13.870 100.088 14.928
201609 15.662 99.604 16.939
201612 8.247 99.380 8.939
201703 13.180 100.040 14.192
201706 15.003 100.285 16.116
201709 15.970 100.254 17.160
201712 16.497 100.213 17.733
201803 15.624 100.836 16.691
201806 65.040 101.435 69.071
201809 12.906 101.246 13.732
201812 10.014 100.906 10.690
201903 14.742 101.571 15.635
201906 55.898 102.044 59.009
201909 17.570 101.396 18.666
201912 9.241 101.063 9.850
202003 22.276 101.048 23.747
202006 18.697 100.743 19.992
202009 18.556 100.585 19.873
202012 18.301 100.241 19.667
202103 18.601 100.800 19.878
202106 25.480 101.352 27.081
202109 25.086 101.533 26.615
202112 148.521 101.776 157.199
202203 19.712 103.205 20.575
202206 15.491 104.783 15.926
202209 14.483 104.835 14.882
202212 13.257 104.666 13.644
202303 19.467 106.245 19.738
202306 19.030 106.576 19.235
202309 14.806 106.570 14.966
202312 68.915 106.461 69.731
202403 21.741 107.355 21.815
202406 29.129 107.991 29.057
202409 30.914 107.468 30.987
202412 29.407 107.128 29.570
202503 37.234 107.722 37.234

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novartis AG  (MEX:NVS N) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novartis AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novartis AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines